Thursday, March 26, 2026
Home Authors Posts by Ogkologos

Ogkologos

4176 POSTS 0 COMMENTS

Rare Cancers Forum 2026: ESMO Leads European Efforts to Turn Evidence...

Ogkologos -
0

FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF...

Ogkologos -
0

Adjuvant Imatinib Prolongs RFS and OS in Patients with Resected GIST...

Ogkologos -
0

In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in...

Ogkologos -
0

Immune Pathways Help Identify Patients with Cancer and HIV Most Likely...

Ogkologos -
0

Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities

Ogkologos -
0

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent...

Ogkologos -
0

FDA Approves Acalabrutinib with Venetoclax for CLL or SLL

Ogkologos -
0

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with...

Ogkologos -
0

Antitumour Activity of Rezatapopt Provides Proof of Concept for p53 Reactivation...

Ogkologos -
0
123...418Page 2 of 418

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com